EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Associations between Growth Differentiation Factor 15, Cardiac Troponin T, and N-terminal pro-B-type Natriuretic Peptide, and Future Myocardial Fibrosis Assessed by Cardiac Magnetic Resonance Imaging: Data from the Akershus Cardiac Examination 1950 Study

Thakshani Wimalanathan, Michael Fredrik Paus iD, Julia Brox Skranes, Trygve Berge, Arnljot Tveit, Helge Røsjø, Torbjørn Omland, M N Lyngbakken iD, Siri Lagethon Heck

The Journal of Applied Laboratory Medicine · 2025

DOI: 10.1093/jalm/jfae145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, 2025. Verfasst von Thakshani Wimalanathan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Imaging, Division of Diagnostics and Technology, Akershus University Hospital, Lørenskog, Norway. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Troponin T, Peptide Fragments, Natriuretic Peptide, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Myocardial fibrosis is associated with a poor outcome for patients with cardiovascular disease (CVD). Growth differentiation factor 15 (GDF-15) concentrations predict the risk of death in patients with CVD, but the underlying pathophysiological mechanisms are poorly understood. We aimed to assess the associations between biomarkers of cellular stress and inflammation (GDF-15), cardiac injury (cardiac troponin T [cTnT]), and stretch (N-terminal pro-B-type natriuretic peptide [NT-proBNP]), and subsequent focal and diffuse myocardial fibrosis assessed by cardiac magnetic resonance (CMR) imaging.

Methods

We measured GDF-15, cTnT, and NT-proBNP in 200 study participants without known coronary artery disease or renal dysfunction from the population-based Akershus Cardiac Examination 1950 Study at baseline in 2012 to 2015. Focal myocardial scars and diffuse fibrosis were assessed by late gadolinium enhancement imaging and septal extracellular volume fraction (ECV) by CMR 4 to 7 years later. The relationships between cardiac biomarkers and CMR parameters were assessed by logistic regression analysis adjusted for common cardiovascular risk factors.

Results

The median age was 63.9 (interquartile range 63.4–64.5) years and 49% were women. GDF-15 (adjusted odds ratio [aOR] 4.40, 95% CI 1.09–17.72) and cTnT (aOR 1.59, 95% CI 1.01–2.50) were associated with nonischemic scars in the fully adjusted model. cTnT (aOR 2.45, 95% CI 1.41–4.25) and NT-proBNP (aOR 3.12, 95% CI 1.55–6.28) were associated with ischemic scars. None of the biomarkers were significantly associated with elevated ECV.

Conclusions

In a general population cohort, GDF-15, an emerging biomarker of cellular stress and inflammation, associates with nonischemic scars. Biomarkers of myocardial injury and stretch associate with ischemic scars, while no biomarker was associated with diffuse fibrosis as assessed by CMR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Growth Differentiation Factor 15Troponin TPeptide FragmentsNatriuretic Peptide, BrainMyocardiumCardiovascular DiseasesHumansFemaleMaleBiomarkersMiddle AgedFibrosisMagnetic Resonance ImagingAged

Substanzen

Growth Differentiation Factor 15Troponin TBiomarkersPeptide FragmentsNatriuretic Peptide, BrainGDF15 protein, humanpro-brain natriuretic peptide (1-76)

Autor:innen und Institutionen

  • Department of Diagnostic Imaging, Division of Diagnostics and Technology, Akershus University Hospital, Lørenskog, Norway.
  • K.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway.
  • Department of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, Gjettum, Norway.
  • Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Akershus Clinical Research Center (ACR), Division of Research and Innovation, Akershus University Hospital, Lørenskog, Norway.

ORCID-Profile: Michael Fredrik Paus, M N Lyngbakken

Zitieren

APA

Wimalanathan, T., Paus, M. F., Brox Skranes, J., Berge, T., Tveit, A., Røsjø, H., Omland, T., Lyngbakken, M. N., & Lagethon Heck, S. (2025). Associations between Growth Differentiation Factor 15, Cardiac Troponin T, and N-terminal pro-B-type Natriuretic Peptide, and Future Myocardial Fibrosis Assessed by Cardiac Magnetic Resonance Imaging: Data from the Akershus Cardiac Examination 1950 Study. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfae145

Vancouver

Wimalanathan T, Paus MF, Brox Skranes J, Berge T, Tveit A, Røsjø H, et al. Associations between Growth Differentiation Factor 15, Cardiac Troponin T, and N-terminal pro-B-type Natriuretic Peptide, and Future Myocardial Fibrosis Assessed by Cardiac Magnetic Resonance Imaging: Data from the Akershus Cardiac Examination 1950 Study. The Journal of Applied Laboratory Medicine. 2025. doi:10.1093/jalm/jfae145

BibTeX
@article{Wimalanathan2025,
  author = {Wimalanathan, Thakshani and Paus, Michael Fredrik and Brox Skranes, Julia and Berge, Trygve and Tveit, Arnljot and Røsjø, Helge and Omland, Torbjørn and Lyngbakken, M N and Lagethon Heck, Siri},
  title = {Associations between Growth Differentiation Factor 15, Cardiac Troponin T, and N-terminal pro-B-type Natriuretic Peptide, and Future Myocardial Fibrosis Assessed by Cardiac Magnetic Resonance Imaging: Data from the Akershus Cardiac Examination 1950 Study},
  journal = {The Journal of Applied Laboratory Medicine},
  year = {2025},
  doi = {10.1093/jalm/jfae145}
}
Kostenlos starten →